165 related articles for article (PubMed ID: 18500344)
1. The chromatin-remodeling enzyme BRG1 coordinates CIITA induction through many interdependent distal enhancers.
Ni Z; Abou El Hassan M; Xu Z; Yu T; Bremner R
Nat Immunol; 2008 Jul; 9(7):785-93. PubMed ID: 18500344
[TBL] [Abstract][Full Text] [Related]
2. Apical role for BRG1 in cytokine-induced promoter assembly.
Ni Z; Karaskov E; Yu T; Callaghan SM; Der S; Park DS; Xu Z; Pattenden SG; Bremner R
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14611-6. PubMed ID: 16195385
[TBL] [Abstract][Full Text] [Related]
3. Polycomb Repressive Complex 2 Confers BRG1 Dependency on the CIITA Locus.
Abou El Hassan M; Yu T; Song L; Bremner R
J Immunol; 2015 May; 194(10):5007-13. PubMed ID: 25862816
[TBL] [Abstract][Full Text] [Related]
4. Chromatin-remodelling factor BRG1 selectively activates a subset of interferon-alpha-inducible genes.
Huang M; Qian F; Hu Y; Ang C; Li Z; Wen Z
Nat Cell Biol; 2002 Oct; 4(10):774-81. PubMed ID: 12244326
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent.
Pattenden SG; Klose R; Karaskov E; Bremner R
EMBO J; 2002 Apr; 21(8):1978-86. PubMed ID: 11953317
[TBL] [Abstract][Full Text] [Related]
6. A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes.
Zhang Y; Cheng MB; Zhang YJ; Zhong X; Dai H; Yan L; Wu NH; Zhang Y; Shen YF
Cell Res; 2010 Dec; 20(12):1345-60. PubMed ID: 21079652
[TBL] [Abstract][Full Text] [Related]
7. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
Radosevich M; Jager M; Ono SJ
Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of chromatin structure of the murine 3' IgH enhancer and IgG2b germline promoter in response to lipopolysaccharide and CD40 signaling.
Qin X; Tang H
Mol Immunol; 2006 Mar; 43(8):1211-20. PubMed ID: 16099047
[TBL] [Abstract][Full Text] [Related]
10. BRG1 is indispensable for IFN-γ-induced TRIM22 expression, which is dependent on the recruitment of IRF-1.
Wang Y; Gao B; Xu W; Xiong S
Biochem Biophys Res Commun; 2011 Jul; 410(3):549-54. PubMed ID: 21683060
[TBL] [Abstract][Full Text] [Related]
11. The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways.
Alessio N; Squillaro T; Cipollaro M; Bagella L; Giordano A; Galderisi U
Oncogene; 2010 Oct; 29(40):5452-63. PubMed ID: 20697355
[TBL] [Abstract][Full Text] [Related]
12. Brahma-related gene 1-dependent STAT3 recruitment at IL-6-inducible genes.
Ni Z; Bremner R
J Immunol; 2007 Jan; 178(1):345-51. PubMed ID: 17182572
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
[TBL] [Abstract][Full Text] [Related]
14. Brg1 modulates enhancer activation in mesoderm lineage commitment.
Alexander JM; Hota SK; He D; Thomas S; Ho L; Pennacchio LA; Bruneau BG
Development; 2015 Apr; 142(8):1418-30. PubMed ID: 25813539
[TBL] [Abstract][Full Text] [Related]
15. Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.
van der Stoep N; Quinten E; Alblas G; Plancke A; van Eggermond MC; Holling TM; van den Elsen PJ
Mol Immunol; 2007 Mar; 44(8):2036-46. PubMed ID: 17067677
[TBL] [Abstract][Full Text] [Related]
16. Prolonged MHC class II expression and CIITA transcription in human keratinocytes.
Takagi A; Nishiyama C; Kanada S; Niwa Y; Fukuyama K; Ikeda S; Okumura K; Ogawa H
Biochem Biophys Res Commun; 2006 Aug; 347(2):388-93. PubMed ID: 16836979
[TBL] [Abstract][Full Text] [Related]
17. Multiple interactions between BRG1 and MHC class II promoter binding proteins.
Mudhasani R; Fontes JD
Mol Immunol; 2005 Apr; 42(6):673-82. PubMed ID: 15781111
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic alterations of BRG1 leads to cancer development through its nuclear-cytoplasmic shuttling abnormalities.
Gunduz E; Gunduz M; Nagatsuka H; Beder L; Demircan K; Tamamura R; Hatipoglu OF; Mahmut N; Katase N; Naomoto Y; Nagai N
Med Hypotheses; 2006; 67(6):1313-6. PubMed ID: 16824695
[TBL] [Abstract][Full Text] [Related]
19. The role of enhancers as centres for general transcription factor recruitment.
Szutorisz H; Dillon N; Tora L
Trends Biochem Sci; 2005 Nov; 30(11):593-9. PubMed ID: 16126390
[TBL] [Abstract][Full Text] [Related]
20. Nuclear actin is involved in the regulation of CSF1 gene transcription in a chromatin required, BRG1 independent manner.
Song Z; Wang M; Wang X; Pan X; Liu W; Hao S; Zeng X
J Cell Biochem; 2007 Oct; 102(2):403-11. PubMed ID: 17393431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
